CSIMarket
 
Idexx Laboratories Inc  (NASDAQ: IDXX)
 
Price: $502.5750 $-3.95 -0.781%
Day's High: $510.9049987792969 Week Perf: -6.13 %
Day's Low: $ 500.61 30 Day Perf: -11.92 %
Volume (M): 95,268 52 Wk High: $ 769.98
Volume (M$): $ 0 52 Wk Avg: $614.00
Open: $509.88 52 Wk Low: $500.61



 Market Capitalization (Millions $) 39,860
 Shares Outstanding (Millions) 79
 Employees 11,000
 Revenues (TTM) (Millions $) 4,554
 Net Income (TTM) (Millions $) 1,140
 Cash Flow (TTM) (Millions $) 36
 Capital Exp. (TTM) (Millions $) 134

Business Description


IDEXX Laboratories Inc. Overview

IDEXX Laboratories Inc. is a prominent global company specializing in diagnostics, software solutions, and services for the veterinary, livestock, and poultry industries. Established in 1983 and headquartered in Westbrook, Maine, United States, IDEXX has developed a reputation as a leader in animal health, providing veterinarians, livestock producers, and poultry farmers with cutting-edge technology and support to improve animal care and management.

Product Offerings

The company offers a wide variety of products and services designed to enhance animal health management. Some key product categories include:

1. Diagnostic Tests: IDEXX manufactures an array of diagnostic tests tailored for the detection of infectious diseases in animals. Notable examples include tests for parvovirus, Lyme disease, and feline leukemia. These tests are crucial for early detection and treatment of various illnesses in pets and livestock.

2. Point-of-Care Analyzers: IDEXXs point-of-care testing systems, such as the IDEXX VetLab Station and the IDEXX SNAP Pro Analyzer, are designed to deliver quick and accurate test results. This immediacy enables veterinarians to make rapid, informed decisions that lead to improved patient outcomes.

3. Imaging Systems: The company also provides imaging solutions for veterinary practices, enhancing diagnostic capabilities through advanced imaging technology. This allows for better visualization of animal health issues and more effective treatment planning.

4. Software Solutions: IDEXX offers several software products that streamline veterinary practice management. IDEXX Neo, for instance, is a cloud-based practice management software that simplifies various operational tasks such as workflow optimization, billing, appointment scheduling, and direct communication with clients. This software enhances client engagement and overall patient care.

5. Livestock and Poultry Solutions: In addition to veterinary services, IDEXX provides diagnostic solutions and monitoring systems for livestock and poultry health, helping farmers manage herd health, detect diseases early, and comply with regulations.

Global Presence and Workforce

IDEXX Laboratories operates in over 175 countries, making it a truly global entity in the animal health industry. The company has a workforce of more than 9,000 employees who are dedicated to innovation, research, and providing high-quality service to clients.

Financial Performance

IDEXX has achieved impressive financial growth, generating over $2 billion in annual revenue. This growth reflects the increasing demand for veterinary diagnostics and animal health products, driven by a greater focus on pet wellness, livestock productivity, and food safety.

Commitment to Innovation

A significant aspect of IDEXX’s success is its commitment to research and development. The company invests heavily in innovative technologies and solutions aimed at improving animal health care. This continued focus on innovation has resulted in the launch of numerous groundbreaking products, keeping IDEXX at the forefront of the animal healthcare industry.

Workplace Recognition

IDEXX Laboratories has been recognized multiple times as one of the best places to work in the United States. This recognition is attributed to the companys strong corporate culture, commitment to employee development, and focus on creating a positive work environment.

Conclusion

IDEXX Laboratories Inc. stands as a leader in the animal healthcare space through its comprehensive range of diagnostic products, innovative software solutions, and commitment to research and development. With a widespread global presence and a dedicated workforce, IDEXX continues to make significant contributions to veterinary medicine and livestock health, enhancing the quality of care available to animals worldwide.


   Company Address: One IDEXX Drive Westbrook 4092 ME
   Company Phone Number: 556-0300   Stock Exchange / Ticker: NASDAQ IDXX


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
ICCC   -1.5%    
ELAN   -7.02%    
ZTS   -5.16%    
• View Complete Report
   





Fundamental Analysis

Valuation Current
Price to Earnings PE Ratio (TTM) 35.39
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) 8.75
Price to Sales (Expected) -
Price to Book 24.72
PEG (TTM) 1.92

Financial Strength Current
Quick Ratio 0.15
Working Capital Ratio 1.17
Leverage Ratio (MRQ) 1.13
Total Debt to Equity 0.28
Interest Coverage (TTM) -
Debt Coverage (TTM) 3.36

Per Share Current
Earnings (TTM) 14.2 $
Revenues (TTM) 57.42 $
Cash Flow (TTM) 0.45 $
Cash 2.48 $
Book Value 20.33 $
Dividend (TTM) 0 $

Efficiency Current
Revenue per Employee (TTM) 413,981
Net Income per Employee (TTM) 103,605
Receivable Turnover Ratio (TTM) 7.75
Inventory Turnover Ratio (TTM) 4.43
Asset Turnover Ratio (TTM) 1.34

Profitability Ratios Current
Gross Margin (MRQ) 64.04 %
Operating Margin (MRQ) 34.98 %
Net Margin (MRQ) 27.82 %
Net Cash Flow Margin (MRQ) 0 %
Effective Tax Rate (TTM) 19.99 %

Management Effectiveness Current
Return On Assets (TTM) 33.61 %
Return On Investment (TTM) 53.15 %
Return On Equity (TTM) 71.96 %
Dividend Yield -
Pay out Ratio (TTM) -



Idexx Laboratories Inc's Segments
revenue    99.65 % of total Revenue
revenue CAG revenue    92.4 % of total Revenue
revenue Water revenue    4.41 % of total Revenue
revenue LPD revenue    2.85 % of total Revenue
revenue Total CAG Diagnostics recurring revenue CAG revenue    80.68 % of total Revenue
revenue IDEXX VetLab consumables CAG revenue    36.17 % of total Revenue
revenue Rapid assay products CAG revenue    7.45 % of total Revenue
revenue Reference laboratory diagnostic and consulting services CAG revenue    33.85 % of total Revenue
revenue CAG Diagnostics services and accessories CAG revenue    3.21 % of total Revenue
revenue CAG Diagnostics capital - instruments CAG revenue    3.72 % of total Revenue
revenue Total veterinary software services and diagnostic imaging systems CAG revenue    8 % of total Revenue
revenue Recurring revenue CAG revenue    6.45 % of total Revenue
revenue Systems and hardware CAG revenue    1.56 % of total Revenue
Other revenue    0.35 % of total Revenue
United States    63.58 % of total Revenue
Europe the Middle East and Africa    22.53 % of total Revenue
Asia Pacific    8.27 % of total Revenue
Canada    3.59 % of total Revenue
Latin America Caribbean    2.04 % of total Revenue
Rebate and up-front considerations arrangements    0.22 % of total Revenue
Customer commitment arrangements multi-year arrangements    429.55 % of total Revenue
Extended warranties and post contract support    1.47 % of total Revenue
Other    0.35 % of total Revenue
CAG    92.4 % of total Revenue
Water    4.41 % of total Revenue
LPD    2.85 % of total Revenue





Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.